Ibritumomab and Lithium Capsules
Determining the interaction of Ibritumomab and Lithium Capsules and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ibritumomab
Brand name: Y-90 Zevalin, In-111 Zevalin
Synonyms: Ibritumomab Tiuxetan
Generic Name: lithium
Brand name: Lithobid, Eskalith, Lithonate, Lithotabs, Eskalith-CR
Synonyms: Lithium
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ibritumomab-Lithium Capsules and Tablets
- Ibritumomab-Lithium Carbonate
- Ibritumomab-Lithium Carbonate ER Tablets
- Ibritumomab-Lithium Carbonate Tablets
- Ibritumomab-Lithium Citrate Syrup
- Ibritumomab-Lithium Controlled-Release and Extended-Release Tablets
- Lithium Capsules-Ibritumomab Intravenous
- Lithium Capsules-Ibritumomab Tiuxetan
- Lithium Capsules-Ibrutinib
- Lithium Capsules-Ibrutinib Capsules
- Lithium Capsules-Ibrutinib Tablets
- Lithium Capsules-Ibu